{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:54:38Z","timestamp":1782996878371,"version":"3.54.5"},"reference-count":46,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Acute kidney injury (AKI) is a common, complex, and severe clinical syndrome characterized by rapid decline in renal function, combined with tissue damage. Currently, the prevention and treatment of AKI are focused on symptomatic treatment, rather than treating the underlying causes. Therefore, there is no specific treatment to prevent renal injury except for renal dialysis. In this study, we used cisplatin-induced AKI mouse and human kidney-2 (HK-2) cell models to evaluate the renal protective effect of eleutheroside B, an active compound in traditional Chinese medicines. MTT assay was used to detect the effect of eleutheroside B on proliferation of human HK-2 cells in presence and in absence of cisplatin. Western blot and immunostaining were used to detect the protein level of kidney injury molecule-1 (KIM-1), cleaved caspase-3, receptor-interacting protein kinase (RIPK)-1, and RIPK-3. Real-time PCR was used to detect the mRNA levels of chemokines (like monocyte chemotactic protein 1, MCP-1) and pro-inflammatory cytokines including interleukin-6 (IL-6) and tumor necrosis factor (TNF-\u03b1). Flow cytometry assay was used to detect apoptosis of HK-2 cells. In vivo results showed that eleutheroside B reduced the increase in serum creatinine and blood urea nitrogen (BUN) levels in the AKI model. Periodic acid-Schiff staining and Western blot analysis of KIM-1 showed that eleutheroside B alleviated tubular cell injury. Further, eleutheroside B reduced macrophage infiltration and production of inflammatory cytokines, inhibited the activation of nuclear factor (NF)-\u03baB, and inhibited apoptosis and programmed necrosis. The mechanism may be that eleutheroside B can activate the insulin-like growth factor (IGF) pathway and its downstream pathway by downregulating the expression of IGFBP-7, thus promoting cell proliferation. Therefore, our results suggest that eleutheroside B is a potential drug for AKI treatment.<\/jats:p>","DOI":"10.3390\/molecules24213876","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T04:44:31Z","timestamp":1572237871000},"page":"3876","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Eleutheroside B Protects against Acute Kidney Injury by Activating IGF Pathway"],"prefix":"10.3390","volume":"24","author":[{"given":"Hongmei","family":"Zang","sequence":"first","affiliation":[{"name":"School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"Anhui Institute of Innovative Drugs, Hefei 230032, China"},{"name":"Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"Anhui Institute of Innovative Drugs, Hefei 230032, China"},{"name":"Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.kint.2018.09.017","article-title":"How to sharpen a novel sword from AKI basic research","volume":"95","author":"Doi","year":"2019","journal-title":"Kidney Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cnur.2018.07.001","article-title":"Acute Kidney Injury","volume":"53","author":"Farrar","year":"2018","journal-title":"Nurs. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/L18-0015","article-title":"Acute Kidney Injury","volume":"168","author":"Gameiro","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"ITC66","DOI":"10.7326\/AITC201711070","article-title":"Acute Kidney Injury","volume":"167","author":"Levey","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0140-6736(15)60126-X","article-title":"International Society of Nephrology\u2019s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): A human rights case for nephrology","volume":"385","author":"Mehta","year":"2015","journal-title":"Lancet"},{"key":"ref_6","first-page":"279","article-title":"Kidney disease: Improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","author":"Mcdonald","year":"2012","journal-title":"Kidney Int. Suppl."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e001380","DOI":"10.1161\/JAHA.114.001380","article-title":"Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: Insights from the National Cardiovascular Data Registry Cath-PCI Registry","volume":"3","author":"Tsai","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cjca.2017.01.018","article-title":"Risk Prediction Models for Contrast-Induced Acute Kidney Injury Accompanying Cardiac Catheterization: Systematic Review and Meta-analysis","volume":"33","author":"Allen","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/jama.297.16.1801","article-title":"Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery","volume":"297","author":"Wijeysundera","year":"2007","journal-title":"J. Am. Med. Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3892\/etm.2017.4647","article-title":"Curcumin protects against acute renal injury by suppressing JAK2\/STAT3 pathway in severe acute pancreatitis in rats","volume":"14","author":"Zhu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41374-018-0052-5","article-title":"Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death","volume":"98","author":"Gao","year":"2018","journal-title":"Lab. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/labinvest.2017.115","article-title":"Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis","volume":"98","author":"Meng","year":"2018","journal-title":"Lab. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2011.120","article-title":"Apoptosis and acute kidney injury","volume":"80","author":"Havasi","year":"2011","journal-title":"Kidney Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00134-009-1725-8","article-title":"Septic acute kidney injury and tubular apoptosis: Never a Lone Ranger","volume":"36","author":"Honore","year":"2010","journal-title":"Intensive Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nm.2629","article-title":"Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis","volume":"18","author":"Sugimoto","year":"2012","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.fitote.2004.04.010","article-title":"Chronic toxicity of Gynostemma pentaphyllum","volume":"75","author":"Attawish","year":"2004","journal-title":"Fitoterapia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s12272-012-0715-5","article-title":"Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats","volume":"35","author":"Qin","year":"2012","journal-title":"Arch. Pharm Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jep.2008.02.009","article-title":"The molecular mechanism of gypenosides-induced G1 growth arrest of rat hepatic stellate cells","volume":"117","author":"Chen","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1534735411403306","article-title":"Gypenosides suppress growth of human oral cancer SAS cells in vitro and in a murine xenograft model: The role of apoptosis mediated by caspase-dependent and caspase-independent pathways","volume":"11","author":"Lu","year":"2012","journal-title":"Integr. Cancer Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1534735410377198","article-title":"An Experimental Study on the Antileukemia Effects of Gypenosides In Vitro and In Vivo","volume":"10","author":"Hsu","year":"2010","journal-title":"Integr. Cancer Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbagen.2013.12.007","article-title":"Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity","volume":"1840","author":"Kodama","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.2000.278.5.F726","article-title":"Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis","volume":"278","author":"Shiraishi","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt.1625","article-title":"Vonderscher, Renal biomarker qualification submission: A dialog between the FDA-EMEA and Predictive Safety Testing Consortium","volume":"28","author":"Dieterle","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1440-1711.2001.01004.x","article-title":"Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1","volume":"79","author":"Umehara","year":"2001","journal-title":"Immunol. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"De Broe, M.E., Porter, G.A., Bennett, W.M., and Deray, G. (2008). Animal Models for the Assessment of Acute Renal Dysfunction and Injury. Clinical Nephrotoxins, Springer.","DOI":"10.1007\/978-0-387-84843-3"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/1566523218666180214092219","article-title":"Current Understanding of Inflammatory Responses in Acute Kidney Injury","volume":"17","author":"Hu","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/labinvest.2017.120","article-title":"NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation","volume":"98","author":"Meng","year":"2018","journal-title":"Lab. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e2125","DOI":"10.1038\/cddis.2016.37","article-title":"Necroptosis in acute kidney injury: A shedding light","volume":"7","author":"Wang","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.kint.2015.10.008","article-title":"Nonapoptotic cell death in acute kidney injury and transplantation","volume":"89","author":"Linkermann","year":"2016","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1093\/ndt\/gfs373","article-title":"Programmed necrosis in acute kidney injury","volume":"27","author":"Linkermann","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.7150\/thno.35686","article-title":"Conditional knockout of TGF-\u03b2RII\/Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation","volume":"9","author":"Yang","year":"2019","journal-title":"Theranostics"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1042\/CS20190599","article-title":"RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress","volume":"133","author":"Wang","year":"2019","journal-title":"Clin. Sci. (Lond)"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/08977194.2011.614237","article-title":"Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3","volume":"29","author":"Martin","year":"2011","journal-title":"Growth Factors"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1651-2227.1999.tb14349.x","article-title":"Insulin-like growth factor binding proteins: A proposed superfamily","volume":"88","author":"Hwa","year":"1999","journal-title":"Acta Paediatr. Suppl."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/er.2006-0001","article-title":"The role of the IGF system in cancer growth and metastasis: Overview and recent insights","volume":"28","author":"Samani","year":"2007","journal-title":"Endocr. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","article-title":"Insulin-like growth factors and neoplasia","volume":"4","author":"Pollak","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"30322","DOI":"10.1074\/jbc.271.48.30322","article-title":"Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II","volume":"271","author":"Oh","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"ra92","DOI":"10.1126\/scisignal.2003184","article-title":"IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors","volume":"5","author":"Evdokimova","year":"2012","journal-title":"Sci. Signal."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/mt.2015.13","article-title":"Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R\/PI3K\/Akt signaling","volume":"23","author":"Yulyana","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.cellsig.2008.08.017","article-title":"NBS1 is required for IGF-1 induced cellular proliferation through the Ras\/Raf\/MEK\/ERK cascade","volume":"20","author":"Hematulin","year":"2008","journal-title":"Cell. Signal."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.2741\/1755","article-title":"The RAS\/RAF\/MEK\/ERK and PI3K\/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma","volume":"10","author":"Friedegund","year":"2005","journal-title":"Front. Biosci."},{"key":"ref_44","first-page":"511","article-title":"The Ras-Raf-MEK-ERK Pathway in the Treatment of Cancer","volume":"25","author":"Hilger","year":"2002","journal-title":"Onkologie"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ijc.10978","article-title":"A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?","volume":"104","author":"Smalley","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1002\/jcb.28035","article-title":"IGFBP7 regulates sepsis-induced acute kidney injury through ERK1\/2 signaling","volume":"120","author":"Wang","year":"2018","journal-title":"J. Cell. Biochem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/21\/3876\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:29:48Z","timestamp":1760189388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/21\/3876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":46,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["molecules24213876"],"URL":"https:\/\/doi.org\/10.3390\/molecules24213876","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]}}}